Bifocal Tuberculosis with Adalimumab Revealed by Laryngeal Involvement: Case Report
Full Text


Bifocal Tuberculosis
Laryngeal Tuberculosis

How to Cite

El Ouardi, N., Taoubane, L., Zegmout, A., Balouki, M., Sadni, S., & Achemlal, L. (2021). Bifocal Tuberculosis with Adalimumab Revealed by Laryngeal Involvement: Case Report. Galician Medical Journal, 28(1), E202117.


Introduction. Anti-TNF treatment has transformed the treatment of chronic inflammatory rheumatism. Although the therapy can be highly effective, anti-TNF drugs are associated with an increased risk of tuberculosis, especially extra-pulmonary tuberculosis.

Laryngeal tuberculosis is rare and its symptoms are not specific. Laryngeal tuberculosis is often secondary to another localization, particularly pulmonary. In the use of anti-TNF therapy, its development is unusual.

Case report. We report a case of bifocal tuberculosis: laryngeal and pulmonary tuberculosis revealed by laryngeal involvement in a patient aged 41 years with axial spondylarthritis treated with Adalimumab.

Conclusion. This presentation highlights the importance to consider the rare possibility of laryngeal tuberculosis in the presence of atypical otorhinolaryngologic signs under anti-TNF therapy and underlines the importance of looking for other tuberculosis involvement.
Full Text


Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Bréban M, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry. Arthritis & Rheumatism [Internet]. 2009 Jul;60(7):1884–1894. Available from:

Agarwal R, Gupta L, Singh M, Yashaswini N, Saxena A, Khurana N, et al. Primary Laryngeal Tuberculosis: A Series of 15 Cases. Head and Neck Pathology [Internet]. 2018 Sep 24;13(3):339–343. Available from:

Abreu C, Magro F, Santos-Antunes J, Pilão A, Rodrigues-Pinto E, Bernardes J, et al. Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population. Journal of Crohn’s and Colitis [Internet]. 2013 Nov;7(10):e486–e492. Available from:

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF- treatment. Thorax [Internet]. 2005 Oct 1;60(10):800–805. Available from:

Jauregui-Amezaga A, Turon F, Ordás I, Gallego M, Feu F, Ricart E, et al. Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening. Journal of Crohn’s and Colitis [Internet]. 2013 Apr;7(3):208–212. Available from:

Kedia S, Mouli VP, Kamat N, Sankar J, Ananthakrishnan A, Makharia G, et al. Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis. The American Journal of Gastroenterology [Internet]. 2020 Mar;115(3):340–349. Available from:

Abitbol Y, Laharie D, Cosnes J, Allez M, Nancey S, Amiot A, et al. Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort. Journal of Crohn’s and Colitis [Internet]. 2016 Jul 11;10(10):1179–1185. Available from:

Mechal Y, Benaissa E, El mrimar N, Benlahlou Y, Bssaibis F, Zegmout A, et al. Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis. BMC Infectious Diseases [Internet]. 2019 Dec;19(1). Available from:

Yeong C, Byrne AL, Cho J-G, Sintchenko V, Crighton T, Marais BJ. Use of GeneXpert MTB/RIF on a single pooled sputum specimen to exclude pulmonary tuberculosis among hospital inpatients placed in respiratory isolation. International Journal of Infectious Diseases [Internet]. 2020 Mar;92:175–180. Available from:

Sharma SK, Mohan A, Sharma A. Miliary tuberculosis: A new look at an old foe. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases [Internet]. 2016 May;3:13–27. Available from:

Benwill JL, Sarria JC. Laryngeal tuberculosis in the United States of America: A forgotten disease. Scandinavian Journal of Infectious Diseases [Internet]. 2014 Feb 7;46(4):241–249. Available from:

Avula A, Ngu S, Mansour W, Gurala D, Maroun R. A Case of Laryngeal Tuberculosis, Endobronchial Tuberculosis and Pulmonary Tuberculosis Coexistent in an Immunocompetent Host. Cureus [Internet]. 2020 Sep 29. Available from:

Lim J-Y, Kim K-M, Choi EC, Kim Y-H, Kim HS, Choi H-S. Current clinical propensity of laryngeal tuberculosis: review of 60 cases. European Archives of Oto-Rhino-Laryngology [Internet]. 2006 Jul 12;263(9):838–842. Available from:

Hone, Timon, Harney, Donnelly. Laryngeal tuberculosis: an important diagnosis. The Journal of Laryngology & Otology [Internet]. 2000 Nov;114(11):878–880. Available from:

Al-Tawfiq JA. Multifocal systemic tuberculosis: the many faces of an old nemesis. Med Sci Monit. 2007 Apr;13(4) CS56-60. Available from:

Swain SK, Behera IC, Sahu MC. Primary Laryngeal Tuberculosis: Our Experiences at a Tertiary Care Teaching Hospital in Eastern India. Journal of Voice [Internet]. 2019 Sep;33(5):812.e9–812.e14. Available from:

Hurtado Alegre JL, Trigoso Gutierrez A, Matos Prado E, Huaringa Marcelo J. Laryngeal Tuberculosis in Pregnant Women: A Case Report and Review of the Literature. Cureus [Internet]. 2018 Nov 5. Available from:

Topak M, Oysu C, Yelken K, Sahin-Yilmaz A, Kulekci M. Laryngeal involvement in patients with active pulmonary tuberculosis. European Archives of Oto-Rhino-Laryngology [Internet]. 2007 Oct 6;265(3):327–330. Available from:

Lodha J, Sharma A, Virmani N, Bihani A, Dabholkar J. Secondary laryngeal tuberculosis revisited. Lung India [Internet]. 2015;32(5):462-464. Available from:

Bosch A, Conrad A, Fuchsmann C, Prot B, Dumitrescu O, Ferry T, et al. Severe laryngeal and pulmonary tuberculosis under anti-TNF-α therapy. International Journal of Infectious Diseases [Internet]. 2018 Jun;71:65–66. Available from:

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.